Patient Guide: AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 238 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT02511106
Status: ACTIVE_NOT_RECRUITING
Condition: Stage IB-IIIA Non-small Cell Lung Carcinoma
Phase: PHASE3

Where You Can Participate

This study is available at 238 locations across the country.

Top locations include:
  • • Los Angeles, California
  • • Santa Monica, California
  • • Santa Rosa, California
  • • And 235 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy. - Join Clinical Trial NCTNCT02511106

How to Join This Clinical Trial - NCTNCT02511106

Learn how to participate in this PHASE3 trial studying an investigational therapy for Stage IB-IIIA Non-small Cell Lung Carcinoma. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Stage IB-IIIA Non-small Cell Lung Carcinoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Stage IB-IIIA Non-small Cell Lung Carcinoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT02511106 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 238 locations. Find a study site near you:

Clinical Research Site

Los Angeles, California 90048 - United States

Status: Contact for availability

Clinical Research Site

Santa Monica, California 90404 - United States

Status: Contact for availability

Clinical Research Site

Santa Rosa, California 95403 - United States

Status: Contact for availability

Clinical Research Site

Torrance, California 90505 - United States

Status: Contact for availability

Clinical Research Site

Grand Junction, Colorado 81501 - United States

Status: Contact for availability

Clinical Research Site

New Haven, Connecticut 06520 - United States

Status: Contact for availability

Clinical Research Site

Norwalk, Connecticut 06856 - United States

Status: Contact for availability

Clinical Research Site

Fort Myers, Florida 33901 - United States

Status: Contact for availability

Clinical Research Site

Pembroke Pines, Florida 33028 - United States

Status: Contact for availability

Clinical Research Site

St. Petersburg, Florida 33705 - United States

Status: Contact for availability

And 228 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Stage IB-IIIA Non-small Cell Lung Carcinoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships